Cargando…
Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study
BACKGROUND: Transmitted drug resistance (TDR) that affects the effectiveness of the first-line antiretroviral therapy (ART) regimen is becoming prevalent worldwide. However, its prevalence and transmission among HIV-1 treatment-naïve patients in Guangdong, China are rarely reported. We aimed to comp...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422730/ https://www.ncbi.nlm.nih.gov/pubmed/34488793 http://dx.doi.org/10.1186/s12985-021-01653-6 |
_version_ | 1783749334369566720 |
---|---|
author | Lan, Yun Li, Linghua He, Xiang Hu, Fengyu Deng, Xizi Cai, Weiping Li, Junbin Ling, Xuemei Fan, Qinghong Cai, Xiaoli Li, Liya Li, Feng Tang, Xiaoping |
author_facet | Lan, Yun Li, Linghua He, Xiang Hu, Fengyu Deng, Xizi Cai, Weiping Li, Junbin Ling, Xuemei Fan, Qinghong Cai, Xiaoli Li, Liya Li, Feng Tang, Xiaoping |
author_sort | Lan, Yun |
collection | PubMed |
description | BACKGROUND: Transmitted drug resistance (TDR) that affects the effectiveness of the first-line antiretroviral therapy (ART) regimen is becoming prevalent worldwide. However, its prevalence and transmission among HIV-1 treatment-naïve patients in Guangdong, China are rarely reported. We aimed to comprehensively analyze the prevalence of TDR and the transmission clusters of HIV-1 infected persons before ART in Guangdong. METHODS: The HIV-1 treatment-naïve patients were recruited between January 2018 and December 2018. The HIV-1 pol region was amplified by reverse transcriptional PCR and sequenced by sanger sequencing. Genotypes, surveillance drug resistance mutations (SDRMs) and TDR were analyzed. Genetic transmission clusters among patients were identified by pairwise Tamura-Nei 93 genetic distance, with a threshold of 0.015. RESULTS: A total of 2368 (97.17%) HIV-1 pol sequences were successfully amplified and sequenced from the enrolled 2437 patients. CRF07_BC (35.90%, 850/2368), CRF01_AE (35.56%, 842/2368) and CRF55_01B (10.30%, 244/2368) were the main HIV-1 genotypes circulating in Guangdong. Twenty-one SDRMs were identified among fifty-two drug-resistant sequences. The overall prevalence of TDR was 2.20% (52/2368). Among the 2368 patients who underwent sequencing, 8 (0.34%) had TDR to protease inhibitors (PIs), 22 (0.93%) to nucleoside reverse transcriptase inhibitors (NRTIs), and 23 (0.97%) to non-nucleoside reverse transcriptase inhibitors (NNRTIs). Two (0.08%) sequences showed dual-class resistance to both NRTIs and NNRTIs, and no sequences showed triple-class resistance. A total of 1066 (45.02%) sequences were segregated into 194 clusters, ranging from 2 to 414 sequences. In total, 15 (28.85%) of patients with TDR were included in 9 clusters; one cluster contained two TDR sequences with the K103N mutation was observed. CONCLUSIONS: There is high HIV-1 genetic heterogeneity among patients in Guangdong. Although the overall prevalence of TDR is low, it is still necessary to remain vigilant regarding some important SDRMs. |
format | Online Article Text |
id | pubmed-8422730 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-84227302021-09-09 Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study Lan, Yun Li, Linghua He, Xiang Hu, Fengyu Deng, Xizi Cai, Weiping Li, Junbin Ling, Xuemei Fan, Qinghong Cai, Xiaoli Li, Liya Li, Feng Tang, Xiaoping Virol J Research BACKGROUND: Transmitted drug resistance (TDR) that affects the effectiveness of the first-line antiretroviral therapy (ART) regimen is becoming prevalent worldwide. However, its prevalence and transmission among HIV-1 treatment-naïve patients in Guangdong, China are rarely reported. We aimed to comprehensively analyze the prevalence of TDR and the transmission clusters of HIV-1 infected persons before ART in Guangdong. METHODS: The HIV-1 treatment-naïve patients were recruited between January 2018 and December 2018. The HIV-1 pol region was amplified by reverse transcriptional PCR and sequenced by sanger sequencing. Genotypes, surveillance drug resistance mutations (SDRMs) and TDR were analyzed. Genetic transmission clusters among patients were identified by pairwise Tamura-Nei 93 genetic distance, with a threshold of 0.015. RESULTS: A total of 2368 (97.17%) HIV-1 pol sequences were successfully amplified and sequenced from the enrolled 2437 patients. CRF07_BC (35.90%, 850/2368), CRF01_AE (35.56%, 842/2368) and CRF55_01B (10.30%, 244/2368) were the main HIV-1 genotypes circulating in Guangdong. Twenty-one SDRMs were identified among fifty-two drug-resistant sequences. The overall prevalence of TDR was 2.20% (52/2368). Among the 2368 patients who underwent sequencing, 8 (0.34%) had TDR to protease inhibitors (PIs), 22 (0.93%) to nucleoside reverse transcriptase inhibitors (NRTIs), and 23 (0.97%) to non-nucleoside reverse transcriptase inhibitors (NNRTIs). Two (0.08%) sequences showed dual-class resistance to both NRTIs and NNRTIs, and no sequences showed triple-class resistance. A total of 1066 (45.02%) sequences were segregated into 194 clusters, ranging from 2 to 414 sequences. In total, 15 (28.85%) of patients with TDR were included in 9 clusters; one cluster contained two TDR sequences with the K103N mutation was observed. CONCLUSIONS: There is high HIV-1 genetic heterogeneity among patients in Guangdong. Although the overall prevalence of TDR is low, it is still necessary to remain vigilant regarding some important SDRMs. BioMed Central 2021-09-06 /pmc/articles/PMC8422730/ /pubmed/34488793 http://dx.doi.org/10.1186/s12985-021-01653-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Lan, Yun Li, Linghua He, Xiang Hu, Fengyu Deng, Xizi Cai, Weiping Li, Junbin Ling, Xuemei Fan, Qinghong Cai, Xiaoli Li, Liya Li, Feng Tang, Xiaoping Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study |
title | Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study |
title_full | Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study |
title_fullStr | Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study |
title_full_unstemmed | Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study |
title_short | Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study |
title_sort | transmitted drug resistance and transmission clusters among hiv-1 treatment-naïve patients in guangdong, china: a cross-sectional study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422730/ https://www.ncbi.nlm.nih.gov/pubmed/34488793 http://dx.doi.org/10.1186/s12985-021-01653-6 |
work_keys_str_mv | AT lanyun transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy AT lilinghua transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy AT hexiang transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy AT hufengyu transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy AT dengxizi transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy AT caiweiping transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy AT lijunbin transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy AT lingxuemei transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy AT fanqinghong transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy AT caixiaoli transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy AT liliya transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy AT lifeng transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy AT tangxiaoping transmitteddrugresistanceandtransmissionclustersamonghiv1treatmentnaivepatientsinguangdongchinaacrosssectionalstudy |